default author photo

Michaela Lukacova

University of Copenhagen

SCHOLARLY PAPERS

1

DOWNLOADS

87

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Dapiglutide, a Dual GLP-1 and GLP-2 Receptor Agonist, for Obesity: A Randomised, Double-Blind, Placebo-Controlled Parallel-Group, Proof-of-Concept Trial

Number of pages: 24 Posted: 30 Aug 2025
University of Copenhagen, University of Copenhagen, University of Copenhagen - Section of Biostatistics, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen - Department of Biomedical Sciences, University of Copenhagen - Gentofte Hospital and University of Copenhagen
Downloads 87 (759,537)

Abstract:

Loading...

Obesity, GLP-1/GLP-2 receptor dual agonism, body weight management